R
Recipharm
Biotech & Life Sciences · Stockholm, Sweden · Founded 1995 · IPO 2014 Thoroughbred
Global footprint
Where Recipharm has talent and traffic
(1 of 3,131 staff)
team presence
across markets
Capital deployed
Recipharm's 10 investments and acquisitions.
Every disclosed deal where Recipharm appeared as a backer or acquirer, 2014–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
10 deals across Recipharm's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Recipharm's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Recipharm
An AI-synthesized read of the highest-engagement posts about Recipharm on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Recipharm on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.